← FDA Drug Approvals (Drugs@FDA)
CHLORPROMAZINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: THINQ PHARM-CRO PVT · Approved 2024-12-10
Drug application
- FDA Application #
ANDA216724- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CHLORPROMAZINE HYDROCHLORIDE
- Generic name
- CHLORPROMAZINE HYDROCHLORIDE
- Active ingredients
- CHLORPROMAZINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- THINQ PHARM-CRO PVT
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2024-12-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown